Yitzhak Tor

Dr. Tor is co-founder and Chief Scientific Advisor, Chemistry of TEGA Therapeutics, Inc. Dr. Tor is also a Professor in the Department of Chemistry and Biochemistry at the University of California, San Diego.

Dr. Tor's research includes chemistry and biology of nucleosides, nucleotides and nucleic acids, the discovery of novel antiviral and antibacterial agents, as well as the development of cellular delivery agents and biomolecular fluorescent probes. He also serves as the Editor in Chief of Perspectives in Medicinal Chemistry and Organic Chemistry Insights. Dr. Tor is the original inventor of guanidinoglycosides. Dr. Tor earned his Ph.D. at the Weizmann Institute of Science and completed his postdoctoral Fellowship at the California Institute of Technology.